Mind Club

Data as of 11.07.2026 · Primary sources linked · NOT INVESTMENT ADVICE

Disease Pipeline Tools Obesity

Obesity

Programs, trials, and reported weight change for obesity and overweight.

Data as of 11.07.2026

All studies

Setmelanotide

Setmelanotide for the Treatment of Leptin Receptor (LEPR) Deficiency Obesity

Rhythm · Phase 3 · Completed · Enrollment 15

NCT03287960

EudraCT 2017-002005-36

ArmPopulationDoseWeeksEstimandWeight change
SetmelanotideObesity or overweightn/r12n/r-12.34% at week 52